Difference between revisions of "Part:BBa K5301017"
| (4 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
</div></div></div></div> | </div></div></div></div> | ||
| − | + | ==Usage and Biology== | |
mSA is used for binding to biotinylated proteins, and sGFP1-10 and sGFP11 self-assemble to form GFP, thereby creating a protein dimer that can report the outcome with fluorescence. | mSA is used for binding to biotinylated proteins, and sGFP1-10 and sGFP11 self-assemble to form GFP, thereby creating a protein dimer that can report the outcome with fluorescence. | ||
| − | + | ==Characterization== | |
| − | ==PCR== | + | ===PCR=== |
We conducted colony PCR validation to assess the feasibility of the plasmid pathway, as shown in Figure 2, where the corresponding bands are very clear, indicating that the target fragments were successfully introduced into the plasmid and transformed into the bacterial strain. | We conducted colony PCR validation to assess the feasibility of the plasmid pathway, as shown in Figure 2, where the corresponding bands are very clear, indicating that the target fragments were successfully introduced into the plasmid and transformed into the bacterial strain. | ||
| Line 25: | Line 25: | ||
</div></div></div></div> | </div></div></div></div> | ||
| − | ==SDS-PAGE== | + | ===SDS-PAGE=== |
SDS-PAGE was used to verify the purification of the sGFP1-10 tether. Due to the particularity of mSA, we simultaneously purified the soluble proteins from the supernatant and the inclusion body proteins from the pellet after bacterial lysis. It was observed that the concentration and purity of the purified inclusion body proteins were high, while the concentration of the soluble proteins was low. Further exploration of soluble protein expression or assessment of inclusion body protein activity could be conducted subsequently. | SDS-PAGE was used to verify the purification of the sGFP1-10 tether. Due to the particularity of mSA, we simultaneously purified the soluble proteins from the supernatant and the inclusion body proteins from the pellet after bacterial lysis. It was observed that the concentration and purity of the purified inclusion body proteins were high, while the concentration of the soluble proteins was low. Further exploration of soluble protein expression or assessment of inclusion body protein activity could be conducted subsequently. | ||
| Line 40: | Line 40: | ||
</div></div></div></div> | </div></div></div></div> | ||
| − | ==ELISA== | + | ===ELISA=== |
| − | We conducted an activity analysis of sGFP tethers. Using the standard interaction between streptavidin and biotin as a control, we observed the interaction between the expressed protein and biotin to determine the activity of the expressed sGFP tether. Observations from Figure | + | We conducted an activity analysis of sGFP tethers. Using the standard interaction between streptavidin and biotin as a control, we observed the interaction between the expressed protein and biotin to determine the activity of the expressed sGFP tether. Observations from Figure 5 indicated that the directly purified soluble sGFP1-10 tether exhibited some activity, while the inclusion body proteins, after purification through denaturation and refolding, didn't exhibit activity. |
| − | <div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:min-content;"><div style="zoom: | + | <div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:min-content;"><div style="zoom:0.15;overflow:hidden;"> |
| − | https://static.igem.wiki/teams/5301/parts/elisa.png | + | https://static.igem.wiki/teams/5301/parts/elisa-2.png |
</div><div class="thumbcaption"> | </div><div class="thumbcaption"> | ||
| − | Figure | + | Figure 5.ELISA of the sGFP1-10 tether. |
Row A, wells 1-9 contain a gradient of mSA standard solutions, while wells 10 and 11 are negative controls with 0.5% BSA. | Row A, wells 1-9 contain a gradient of mSA standard solutions, while wells 10 and 11 are negative controls with 0.5% BSA. | ||
Row B, wells 1-10 also contain a gradient of mSA standard solutions, and wells 11 and 12 are negative controls with 0.5% BSA. | Row B, wells 1-10 also contain a gradient of mSA standard solutions, and wells 11 and 12 are negative controls with 0.5% BSA. | ||
| Line 57: | Line 57: | ||
<!-- --> | <!-- --> | ||
| − | + | ==Sequence and Features== | |
<partinfo>BBa_K5301017 SequenceAndFeatures</partinfo> | <partinfo>BBa_K5301017 SequenceAndFeatures</partinfo> | ||
Latest revision as of 09:42, 2 October 2024
sGFP1-10 tether is composed of mSA, a 3C linker, a 6His tag, and sGFP 1-10.
sGFP1-10 tether is composed of mSA (BBa_K4623001), a 3C linker, a 6×His tag, and sGFP 1-10 (BBa_K5301012).We construct membrane protein dimers through the interaction between biotin and streptavidin, as well as the self-assembly mechanism of sGFP.
Figure 1.AlphaFold2 predition of the sGFP1-10 tether.
Usage and Biology
mSA is used for binding to biotinylated proteins, and sGFP1-10 and sGFP11 self-assemble to form GFP, thereby creating a protein dimer that can report the outcome with fluorescence.
Characterization
PCR
We conducted colony PCR validation to assess the feasibility of the plasmid pathway, as shown in Figure 2, where the corresponding bands are very clear, indicating that the target fragments were successfully introduced into the plasmid and transformed into the bacterial strain.
Figure 2.PCR result of the sGFP1-10 tether.The base sequence length of the sGFP1-10 tether is 1071 base pairs (bp)
SDS-PAGE
SDS-PAGE was used to verify the purification of the sGFP1-10 tether. Due to the particularity of mSA, we simultaneously purified the soluble proteins from the supernatant and the inclusion body proteins from the pellet after bacterial lysis. It was observed that the concentration and purity of the purified inclusion body proteins were high, while the concentration of the soluble proteins was low. Further exploration of soluble protein expression or assessment of inclusion body protein activity could be conducted subsequently.
Figure 3.SDS-PAGE of the soluble sGFP1-10 tether.The molecular weight of the sGFP1-10 tether is 39.2kDa.
Figure 4.SDS-PAGE of the inclusion body sGFP1-10 tether.The molecular weight of the sGFP1-10 tether is 39.2kDa.
ELISA
We conducted an activity analysis of sGFP tethers. Using the standard interaction between streptavidin and biotin as a control, we observed the interaction between the expressed protein and biotin to determine the activity of the expressed sGFP tether. Observations from Figure 5 indicated that the directly purified soluble sGFP1-10 tether exhibited some activity, while the inclusion body proteins, after purification through denaturation and refolding, didn't exhibit activity.
Figure 5.ELISA of the sGFP1-10 tether. Row A, wells 1-9 contain a gradient of mSA standard solutions, while wells 10 and 11 are negative controls with 0.5% BSA. Row B, wells 1-10 also contain a gradient of mSA standard solutions, and wells 11 and 12 are negative controls with 0.5% BSA. Row C, wells 1 and 4 are refolded samples of sGFP1-10 tether protein. Row D, well 1 contains purified samples of sGFP1-10 tether protein. Rows E and F, well 2 contains purified inclusion body samples of sGFP1-10 tether.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 82
Illegal AgeI site found at 142 - 1000COMPATIBLE WITH RFC[1000]